increased histiocytic sarcoma incidence_Suz12<Gt(Betageo)1Khe>/Suz12<+>

http://metadb.riken.jp/0009321I129P2OlaHsdSuz12GtBetageo1KheSuz12Suz12GtBetageo1KheSuz12

increased histiocytic sarcoma incidence_Suz12<Gt(Betageo)1Khe>/Suz12<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• suppressor of zeste 12 homolog (Drosophila)
  http://metadb.riken.jp/db/mgi_rdf/MGI:1261758

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Suz12<Gt(Betageo)1Khe>/Suz12<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Suz12<Gt(Betageo)1Khe>|Suz12<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased histiocytic sarcoma incidence
  http://purl.obolibrary.org/obo/MP_0009321

文献

http://purl.org/net/cito/citesAsAuthority

• Thomas. De Raedt, et.al., PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies., Nature, 2014, 514
  http://rdf.ncbi.nlm.nih.gov/pubmed/25119042